Franck Amblard
Franck Amblard
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Sebastien Boucle
Sebastien Boucle
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Leda Bassit
Leda Bassit
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Bryan Cox
Bryan Cox
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Ozkan Sari
Ozkan Sari
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Sijia Tao
Sijia Tao
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Zhe Chen
Zhe Chen
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Tugba Ozturk
Tugba Ozturk
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Kiran Verma
Kiran Verma
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Olivia Russell
Olivia Russell
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a, 
Virgile Rat
Virgile Rat
bMorphogenèse et Antigénicité du VIH et des Virus des Hépatites, Inserm – U1259 MAVIVH, Hôpital Bretonneau, Tours, France
 
b, 
Hugues de Rocquigny
Hugues de Rocquigny
bMorphogenèse et Antigénicité du VIH et des Virus des Hépatites, Inserm – U1259 MAVIVH, Hôpital Bretonneau, Tours, France
 
b, 
Oriane Fiquet
Oriane Fiquet
cInnate Immunity Unit, Institut Pasteur, Paris, France
dInserm U1223, Paris, France
 
c,d, 
Maud Boussand
Maud Boussand
cInnate Immunity Unit, Institut Pasteur, Paris, France
dInserm U1223, Paris, France
 
c,d, 
James Di Santo
James Di Santo
cInnate Immunity Unit, Institut Pasteur, Paris, France
dInserm U1223, Paris, France
 
c,d, 
Helene Strick-Marchand
Helene Strick-Marchand
cInnate Immunity Unit, Institut Pasteur, Paris, France
dInserm U1223, Paris, France
 
c,d, 
Raymond F Schinazi
Raymond F Schinazi
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
 
a,✉
 
aCenter for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA
bMorphogenèse et Antigénicité du VIH et des Virus des Hépatites, Inserm – U1259 MAVIVH, Hôpital Bretonneau, Tours, France
cInnate Immunity Unit, Institut Pasteur, Paris, France
dInserm U1223, Paris, France
✉Address correspondence to Raymond F. Schinazi, rschina@emory.edu.
 
Citation Amblard F, Boucle S, Bassit L, Cox B, Sari O, Tao S, Chen Z, Ozturk T, Verma K, Russell O, Rat V, de Rocquigny H, Fiquet O, Boussand M, Di Santo J, Strick-Marchand H, Schinazi RF. 2020. Erratum for Amblard et al., “Novel hepatitis B virus capsid assembly modulator induces potent antiviral responses in vitro and in humanized mice.” Antimicrob Agents Chemother 64:e01351-20. https://doi.org/10.1128/AAC.01351-20.
 
 
Collection date 2020 Sep.